Cargando…
Prognostic value of plasma sAXL in patients with heart failure: insights from the DRAGON‐HF trial
BACKGROUND: Little is known about the predictive value of soluble AXL (sAXL) in heart failure (HF). This study aimed to describe the prognostic value of plasma sAXL in patients with symptomatic HF. METHODS: This is a multicentre observational prospective cohort study (Registration No. NCT03727828)....
Autores principales: | Liu, Yifan, Wang, Xiaoyu, Pan, Xin, Ma, Teng, Xu, Yawei, Fen, Qimao, Nijiati, Muyesai, Chi, Chen, Su, Yang, Zhang, Xianling, Xu, Dachun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871665/ https://www.ncbi.nlm.nih.gov/pubmed/36436827 http://dx.doi.org/10.1002/ehf2.14241 |
Ejemplares similares
-
Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus
por: Ekman, Carl, et al.
Publicado: (2011) -
Plasma GAS6 predicts mortality risk in acute heart failure patients: insights from the DRAGON-HF trial
por: Ma, Teng, et al.
Publicado: (2023) -
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors
por: Apostolo, Daria, et al.
Publicado: (2023) -
Elevated Levels of Soluble Axl (sAxl) Regulates Key Angiogenic Molecules to Induce Placental Endothelial Dysfunction and a Preeclampsia-Like Phenotype
por: Gui, Shunping, et al.
Publicado: (2021) -
Proseek single-plex protein assay kit system to detect sAxl and Gas6 in serological material of brain tumor patients
por: Jaksch-Bogensperger, Heidi, et al.
Publicado: (2018)